Campylobacter jejuni bacteremia in a patient with acute lymphocytic leukemia
Introduction : Campylobacter jejuni is a slender, motile, non-spore-forming, helical-shaped, gram-negative bacterium. It isoneof the most common causes of human gastroenteritis in the world. The aim of this study was to present a patient with acute lymphocytic leukemia (ALL), who was infected with C...
Saved in:
Published in | Iranian red crescent medical journal Vol. 18; no. 6; pp. 1 - 4 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Dubai, United Arab Emirates
Iranian Hospital
01.06.2016
Zamen Salamati Publishing Kowsar |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Introduction : Campylobacter jejuni is a slender, motile, non-spore-forming, helical-shaped, gram-negative bacterium. It isoneof the
most common causes of human gastroenteritis in the world. The aim of this study was to present a patient with acute lymphocytic
leukemia (ALL), who was infected with Campylobacter jejuni.
Case Presentation: We describe the medical records of a pediatric ALL patient with bacteremia caused by C. jejuni, who was diagnosed
at Amir hospital, Shiraz, Iran. This 14-year-old male visited the emergency department of Amir hospital with night sweats,
severe polar high-grade fever, reduced appetite, and nausea in August 2013. Given the suspected presence of an anaerobic or microaerophilic
microorganism, aerobic and anaerobic blood cultures were performed using an automated blood cultivator, the
BACTEC 9240 system. In order to characterize the isolate, diagnostic biochemical tests were used. Antibiotic susceptibility testing
was done with the disk diffusion method. The primary culture was found to be positive for Campylobacter, and the subculture of
the solid plate yielded a confluent growth of colonies typical for Campylobacter, which was identified as C. jejuni by morphological
and biochemical tests. The isolate was resistant to ciprofloxacin, cefotaxime, cephalexin, piperacillin/tazobactam, nalidixic acid,
aztreonam, cefuroxime, cefixime, ceftazidime, and tobramycin.
Conclusions: C. jejuni should be considered in the differential diagnosis as a potential cause of bacteremia in immunosuppressed
patients. In caseswheretheBACTECresult is positive in aerobic conditions but the organism cannot be isolated, ananaerobic culture
medium is suggested, especially in immunocompromised patients. |
---|---|
ISSN: | 2074-1804 2074-1812 |
DOI: | 10.5812/ircmj.23992 |